Sustained postoperative anaemia is associated with an impaired outcome after coronary artery bypass graft surgery: Insights from the IMAGINE trial

Heart

Volumn 97, Issue 19, 2011, Pages 1590-1596

  Westenbrink, B Daan ^a   Kleijn, Lennaert ^a   De Boer, Rudolf A ^a   Tijssen, Jan G ^b   Warnica, Wayne J ^c   Baillot, Richard ^d   Rouleau, Jean L ^e   Van Gilst, Wiek H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF CALGARY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PLACEBO; QUINAPRIL;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANEMIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; FEMALE; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TETRAHYDROISOQUINOLINES; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052677080     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300118     Document Type: Article

References (23)

1. Reinecke H, Trey T, Wellmann J, et al. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 2003;24:2142-50. (Pubitemid 37486534)
2. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of haemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111:2042-9. (Pubitemid 40577898)
3. Van der Meer P, Groenveld HF, Januzzi JL, et al. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart 2009;95:1309-14.
4. Sarnak MJ, Tighiouart H, Manjunath G, et al. Anaemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002;40:27-33. (Pubitemid 34701373)
5. Wu WC, Schifftner TL, Henderson WG, et al. Pre-operative hematocrit levels and post-operative outcomes in older patients undergoing noncardiac surgery. JAMA 2007;297:2481-8. (Pubitemid 46953401)
6. Van Straten AH, Hamad MA, Van Zundert AJ, et al. Pre-operative haemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population. Circulation 2009;120:118-25.
7. Ranucci M, Conti D, Castelvecchio S, et al. Hematocrit on cardiopulmonary bypass and outcome after coronary surgery in nontransfused patients. Ann Thorac Surg 2010;89:11-17.
8. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006;81:1650-7. (Pubitemid 350030027)
9. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, post-operative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-52. (Pubitemid 350179219)
10. Oliver E, Carrio ML, Rodríguez-Castro D, et al. Relationships among haemoglobin level, packed red cell transfusion and clinical outcomes in patients after cardiac surgery. Intensive Care Med 2009;35:1548-55.
11. Warnica JW, Gilst WV, Baillot R, et al. Ischemia Management with Quinapril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomised trial - design and rationale. Can J Cardiol 2002;18:1191-200. (Pubitemid 36040588)
12. Rouleau JL, Warnica WJ, Baillot R, et al. Effects of angiotensin- converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. IMAGINE (Ischemia Management with Quinapril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators. Circulation 2008;117:24-31.
13. Van der Meer P, Lipsic E, Westenbrink BD, et al. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anaemia in heart failure. Circulation 2005;112:1743-7. (Pubitemid 41368150)
14. Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anaemia, and the impact of incident anaemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2005;45:391-9. (Pubitemid 40186790)
15. Surgenor SD, DeFoe GR, Fillinger MP, et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of post-operative low-output heart failure. Circulation 2006;114(1 Suppl):I43-8. (Pubitemid 44297127)
16. Spiess BD, Ley C, Body SC, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Peri-operative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg 1998;116:460-7. (Pubitemid 28400176)
17. Ferraris VA, Ferraris SP, Saha SP, et al. Peri-operative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007;83:27-86.
18. Westenbrink BD, Visser FW, Voors AA, et al. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J 2007;28:166-71.
19. Westenbrink BD, De Boer RA, Voors AA, et al. Anaemia in chronic heart failure: etiology and treatment options. Curr Opin Cardiol 2008;23:141-7. (Pubitemid 351321582)
20. Ripamonti V, Racca V, Calvo MG, et al. Angiotensin converting enzyme inhibitors slow recovery from anaemia following cardiac surgery. Chest 2006;130:79-84. (Pubitemid 44116844)
21. Miceli A, Capoun R, Fino C, et al. Effect of angiotensin-converting enzyme inhibitor therapy on outcome after coronary artery bypass grafting. J Am Coll Cardiol 2009;54:1778-84.
22. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008;358:1229-39. (Pubitemid 351439224)
23. Murphy GJ. Does blood transfusion harm cardiac surgery patients? BMC Med 2009;7:38-40.